Cargando…
Plasmavigilance—Adverse events among US Source plasma donors
BACKGROUND: Source plasma (SP) is the primary starting material for 87% of plasma‐derived medicinal products globally. Plasmavigilance is a program designed to collect, analyze, and monitor donor adverse events (AEs) across the SP collection industry. Donor retention depends on donors having a safe...
Autores principales: | Schreiber, George B., Becker, Mark, Fransen, Michelle, Hershman, Janet, Lenart, James, Song, Guang, Simon, Toby |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291118/ https://www.ncbi.nlm.nih.gov/pubmed/34390267 http://dx.doi.org/10.1111/trf.16612 |
Ejemplares similares
-
Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone
por: Tedder, Richard S., et al.
Publicado: (2018) -
The healthy donor effect and survey participation, becoming a donor and donor career
por: Brodersen, Thorsten, et al.
Publicado: (2022) -
Donor and non‐donor perspectives on receiving information from routine genomic testing of donor blood
por: Thorpe, Rachel, et al.
Publicado: (2022) -
Do deferred donors continue their donations? A large‐scale register study on whole blood donor return in the Netherlands
por: Spekman, Marloes L.C., et al.
Publicado: (2019) -
Personalized collection of plasma from healthy donors: A randomized controlled trial of a novel technology‐enabled nomogram
por: Hartmann, Jan, et al.
Publicado: (2021)